TRODELVY (sacituzumab govitecan-hziy) for injection
Brand Name: TRODELVY Generic Name: sacituzumab govitecan-hziy. It is used to treat adults with a type of breast cancer known as triple-negative breast cancer.
TRODELVY is a Trop-2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of adult patients with metastatic triple-negative breast cancer (mTNBC) who have received at least two prior therapies for metastatic disease.
| Brand Name: | TRODELVY |
| Generic Name: | sacituzumab govitecan-hziy |
| Strength: | • For injection: 180 mg lyophilized powder in single-dose vials for reconstitution. |
| Manufacturer: | Gilead Sciences, Inc. |
| Approved By: | EMA, USFDA |
Source content : www.accessdata.fda.gov
Get Access to TRODELVY (sacituzumab govitecan-hziy) for injection in India
To know the best price of the TRODELVY (sacituzumab govitecan-hziy) for injectionn available with Lucknow Speciality Pharma call at Contact No. M: 9336559090 or WhatsApp at 9336559090 or email us at info@lucknowpharma.com
Disclaimer: All Trademarks and Brands that appear on the website belong to their respective owners and Lucknow Speciality Pharma (www.lucknowpharma.com) does not lay any claim on them we only provide Information.
Disclaimer: All Trademarks and Brands that appear on the website belong to their respective owners and Lucknow Speciality Pharma (www.lucknowpharma.com) does not lay any claim on them we only provide Information.
About Us
Lucknow Speciality Pharma is dedicated to delivering life-changing healthcare solutions. As a trusted wholesale supplier of specialized medicines, we cater to critical care areas such as oncology, nephrology, and rare diseases. Our patient-centric approach also includes personalized catering services, ensuring that patients receive the care, support, and nutrition they need to thrive. We also extend our services globally, welcoming international patients and buyers who seek our expertise and high-quality products.
Lucknow Speciality Pharma is a registered Pharmaceutical Firm in Lucknow, India. Registered under GST Act. Registration Number : 09AAOPG3102HIZY. It provide assistance and connectivity with drug pharmacies or distributors for access to genuine medicines at competitive prices.
Get Access To TRODELVY (sacituzumab govitecan-hziy) for injection
Enter Buying Requirements Details
For precise quotations, kindly ensure your requirements include the product name, order quantity, intended usage, and any special requests you may have.
Branch Offices in India : Lucknow | Agra | Varanasi | Gorakhpur | Kanpur | Indore | Patna | Kolkata | Nepal
TRODELVY (sacituzumab govitecan-hziy) medication is used to treat adults with a type of breast cancer known as triple-negative breast cancer.
Sacituzumab govitecan, sold under the brand name Trodelvy, is a Trop-2-directed antibody and topoisomerase inhibitor drug conjugate used for the treatment of metastatic triple-negative breast cancer and metastatic urothelial cancer. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) consider it to be a first-in-class medication.
FDA grants accelerated approval to sacituzumab govitecan-hziy for metastatic triple negative breast cancer. On April 22, 2020, the Food and Drug Administration granted accelerated approval to sacituzumab govitecan-hziy (TRODELVY, Immunomedics, Inc.) for adult patients with metastatic triple-negative breast cancer who received at least two prior therapies for metastatic disease.
sacituzumab govitecan-hziy is available in India on request-
Lucknow Speciality Pharma is the leading Pharma brand and one of the most leading Pharma Wholesalers in Lucknow. We are expanding our reach across India. To get “TRODELVY (sacituzumab govitecan-hziy) for injection in India“, patients can simply fill the order form or, please call us at 9811747774, 9555306364 or WhatsApp at 9555306364, 9555306364 or email us at info@lucknowpharma.com. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
NEWS / UPDATES
- For TRODELVY (sacituzumab govitecan-hziy)Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
- Gilead Announces Clinical Trial Collaboration With Merck to Evaluate Trodelvy® (sacituzumab govitecan-hziy) in Combination With KEYTRUDA® (pembrolizumab) in Patients With First-Line Metastatic Triple-Negative Breast Cancer For More Details
- FDA grants accelerated approval to sacituzumab govitecan-hziy for metastatic triple negative breast cancer For More Details
- Gilead and MSD collab on Trodelvy/Keytruda breast cancer trial For More Details
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 AM and 7:00 PM IST.
Landline :
05226180025
Mobile :
+91 93365 59090
WhatsApp:
+91-9760014849
Email:
info@lucknowpharma.com
